Search

everythinglearnresearchcommunity

for

Search:↓

The study's results on the effectiveness of low-dose IL-2 for alopecia areata and its impact on immune cells were not provided.

Alopecia areata may protect against graft dysfunction, while asthma may increase its risk.

An 84-year-old man developed severe anemia after his first COVID-19 vaccine shot, improved with treatment, and was advised against a second dose.

ICL is a condition with low CD4+ T cells like AIDS but not caused by HIV, and normal CD4+ T cell counts may vary between men and women.

BDNF, TSH, fT4, anti-TPO, and 25-OH Vitamin D levels predict depression risk in patients with autoimmune thyroiditis and hypothyroidism.

Non-biologic immunosuppressive drugs are crucial for treating autoimmune and chronic inflammatory skin diseases.

Multiple pregnancies prevent skin disease but worsen kidney disease in certain mice.

A new plant-based treatment was effective for hair regrowth in women with a specific type of hair loss that didn't respond to usual treatments.

Alopecia areata involves immune system issues and specific cell types that disrupt hair growth, leading to hair loss.

The study identified key immune cell differences between mild and severe alopecia areata.

IFN-γ production by CD4 T cells is crucial for causing alopecia areata.

Alopecia areata can be reversed by JAK inhibitors, promoting hair regrowth.

Regulatory T cells help prevent autoimmunity and have potential for treating autoimmune diseases.

Acne patients' skin, both with and without lesions, shows a strong immune response and higher antimicrobial activity.

People with alopecia areata have fewer regulatory T-cells than those with other skin conditions.

Reduced SIRT1 in hair cells may cause alopecia areata by triggering immune responses.

Inflammation damages sweat ducts, causing sweat gland injury.

Alopecia areata involves complex immune and genetic factors, with potential treatment targets identified, but more research is needed.

Activating TLR9 helps heal wounds and regrow hair by using specific immune cells.

Male and female skin differ in many ways, which could lead to gender-specific skin treatments.

CD44 variant changes start alopecia areata, but don't maintain it.

Targeting Vδ1+T-cells may help treat alopecia areata.

T-regulatory cells are important for skin health and can affect hair growth and reduce skin inflammation.

Specific immune cells and pathways contribute to hair follicle inflammation and hair loss, suggesting potential treatments for lichen planopilaris.

Natural killer and CD8+ T cells play a key role in hair loss in androgenetic alopecia.

Stem cell treatment from umbilical cords reduces symptoms of atopic dermatitis and may help hair growth.

HDAC4 and HDAC7 are crucial for Th17 cell development and could be targeted to treat inflammatory diseases.

Some treatments for autoimmune hair loss work, but JAK inhibitors like tofacitinib are promising for regrowth.

CAR-T therapy offers hope for children with hard-to-treat blood cancers.

Mice treatments didn't grow hair, a patient treatment may affect immune response, and people with hair loss often feel anxious or depressed.